Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Neutrophilic, Chronic × Cytogenetic Analysis × Clear all

Sponsor

Conditions

Leukemia, Myelomonocytic, Chronic 3 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Congenital Abnormalities 2 Anemia, Refractory, with Excess of Blasts 2 Waldenstrom Macroglobulinemia 1 Thrombocytopenia 1 Smoldering Multiple Myeloma 1 Sezary Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Myelodysplastic-Myeloproliferative Diseases 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Juvenile 1

Interventions

fludarabine phosphate 9 Cyclophosphamide 7 Busulfan 7 Antilymphocyte Serum 7 Whole-Body Irradiation 6 Peripheral Blood Stem Cell Transplantation 6 Mycophenolic Acid 6 Tacrolimus 5 Methotrexate 5 Cyclosporine 5 thymoglobulin 4 Melphalan 4 Rituximab 3 Etoposide 3 Cord Blood Stem Cell Transplantation 3 Sirolimus 2 Radiotherapy 2 Ondansetron 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cytarabine 2 Carmustine 2 Calcium Dobesilate 2 Aprepitant 2 ruxolitinib 1 etoposide phosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carmustine, poliferprosan 20 drug combination 1 Sugars 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡